MyFinsight
Home
Blog
About
Contact
Deferred revenue
$755,553
Sale of marketable
securities
$593,473
Accounts payable
$430,737
Depreciation and
amortization expense
$244,212
Losses on marketable
securities
-$240,458
Provision for doubtful
accounts
$213,341
Prepaid expenses
-$178,529
Compensatory element of stock
options
$158,549
Amortization of operating
lease right-of-use...
$97,787
Inventory
-$51,803
Net income
$47,108
Other current assets
-$24,435
Amortization of debt issuance
costs
$5,136
Net cash from
operating activities
$651,827
Net cash from (used)
in investing...
$19,104
Canceled cashflow
$1,795,821
Canceled cashflow
$574,369
Decrease in cash and cash
equivalents
-$69,359
Canceled cashflow
$670,931
Proceeds from line of
credit
$1,200,000
Accrued expenses
-$1,390,667
Accounts receivable
$182,853
Deposits and other
assets, net
$112,647
Operating lease liability
-$109,654
Purchases of marketable
securities
$507,304
Purchases of property and
equipment
$67,065
Net cash (used in)
provided by financing...
-$740,290
Canceled cashflow
$1,200,000
Repayment of line of credit
$1,900,000
Repayments of note payable
$40,290
Back
Back
Cash Flow
CRYO CELL INTERNATIONAL INC (CCEL)
CRYO CELL INTERNATIONAL INC (CCEL)
source: myfinsight.com